The impact of respiratory disease during a 150-d feedlot finishing period on daily gain, carcass traits, and longissimus tenderness was measured using 204 steer calves. Feedlot health status was monitored in two ways. First, clinical signs of respiratory infection were evaluated each day; treatment with antibiotic was based on degree of fever (if rectal temperature exceeded 40 degrees C then calves were treated). Steers that were treated (n = 102) had lower (P<.05) final live weights, ADG, hot carcass weights (HCW), less external and internal fat, and more desirable yield grades. Steers that were treated had a higher prevalence of carcasses that graded U.S. Standard than steers that were never treated. Second, as an alternative index of health status, lungs of all steers were evaluated at the processing plant using a respiratory tract lesion classification system; this health index included presence or absence of preexisting pneumonic lesions in the anterioventral lobes plus activity of the bronchial lymph nodes (inactive vs active). Lung lesions were present in 33% of all lungs and were distributed almost equally between treated (37%) and untreated cattle (29%). Steers with lesions (n = 87) had lower (P<.05) daily gains, lighter HCW, less internal fat, and lower marbling scores than steers without lesions. Compared to steers with lesions but inactive bronchial lymph nodes (n = 78), steers with lung lesions plus active lymph nodes had lower (P<.01) ADG and dressing percentage. Longissimus shear force values for steaks aged 7 d were lower (P = .05) from steers without lung lesions than those for steaks from steers with lung lesions. Overall, morbidity suppressed daily gains and increased the percentage of U.S. Standard carcasses. Compared to health assessment by clinical appraisal (based on elevated body temperature), classification based on respiratory tract lesions at slaughter proved more reliable statistically and, thereby, more predictive of adverse effects of morbidity on production and meat tenderness.
The National Beef Quality Audit-1995 was conducted to evaluate the progress of the beef industry since the time of the National Beef Quality Audit-1991 in improving quality and consistency of beef. Nine plants were assigned for auditing to Colorado State University, Oklahoma State University, and Texas A&M University. Personnel from each institution visited three of their nine plants twice, once in the spring/summer and once in the fall/winter. Data were collected on 50% of each lot on the slaughter floor and 10% in the cooler during a single day's production (one or two shifts, as appropriate). Of the cattle audited on the slaughter floor, 47.7% had no brands, 3.0% had a shoulder brand, 16.8% had a side brand, 38.7% had a butt brand, and 6.2% had brands in multiple locations. Data revealed that 51.6% of the carcasses had no bruises, 30.9% had one bruise, 12.8% had two bruises, 3.7% had three bruises, .9% had four bruises, and .1% had more than four bruises. In addition, 7.2% of the bruises evaluated were located on the round, 41.1% were on the loin, 20.8% on the rib, and 30.8% on the chuck. Livers, lungs, tripe, heads, tongues, and whole carcasses were condemned at rates of 22.2, 5.0, 11.0, .9, 3.8, and .1%, respectively. Mean USDA yield grade and quality grade traits were as follows: USDA yield grade, 2.8; carcass weight, 338.4 kg; adjusted fat thickness, 1.2 cm; longissimus muscle area, 81.9 cm2; kidney, pelvic, and heart fat, 2.1%; USDA quality grade, High Select; overall maturity, A60; and marbling score, Small-minus.
Fall-weaned crossbred steer calves (n = 300; 184 +/- 2.9 kg) received either no implant (Control) or were implanted with Synovex-C (SC = 10 mg estradiol benzoate + 100 mg progesterone), Synovex-S (SS = 20 mg estradiol benzoate + 200 mg progesterone), or Revalor-G (RG = 8 mg estradiol-17beta + 40 mg trenbolone acetate) to determine the effects of implants on weight gain during winter grazing on dormant tallgrass prairie, subsequent grazing and finishing performance, and carcass characteristics. Steers grazed two dormant tallgrass prairie pastures from October 16, 1996, until March 29, 1997 (164 d), and received 1.36 kg/d of a 25% CP supplement that supplied 100 mg of monensin/steer. Following winter grazing, all steers were implanted with Ralgro (36 mg zeranol) and grazed a common tallgrass prairie pasture until July 17 (110 d). After summer grazing, all steers were implanted with Revalor-S (24 mg estradiol-17beta + 120 mg trenbolone acetate), and winter implant treatment groups were equally allotted to four feedlot pens. Steers were harvested November 17, 1997, after a 123-d finishing period. Daily gains during the winter grazing phase averaged .28, .32, .32, or .35 kg/d, respectively, for Control, SC, SS, or RG steers and were greater (P < .01) for implanted steers than for Controls. Summer daily gains were similar (1.05 +/- .016 kg/d; P > or = .61) for all treatment groups. Feedlot daily gains were also similar (1.67 +/- .034 kg/d; P > or = .21), with implanted steers weighing 14 kg more than Control steers (P = .05) at harvest, despite similar management during summer grazing and feedlot phases. Control steers tended (P = .06) to have lower yield grades. There were no differences (P = .99) in marbling between implanted and nonimplanted steers. Steers implanted during the wintering phase had increased skeletal and overall (P < .01) carcass maturities compared with nonimplanted steers, which resulted in more "B" and "C" maturity carcasses. Because carcass maturity score affects quality grade, the increased maturities of implanted steers resulted in a $9.04 decrease in carcass value/100 kg (P < .01) compared with Controls. The results of this study indicate that growth-promoting implants are efficacious for cattle wintered on dormant native range despite low daily gains. This increased weight is maintained through the summer grazing and feedlot phases; however, the benefit of the increased weight may be offset by decreased carcass quality grade and value due to increased carcass maturity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.